Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses.

Authors:
Freeman R; Durso-Decruz E; Emir B.

Journal:
Diabetes Care

Publication Year: 2008

DOI:
10.2337/dc07-2105

PMCID:
PMC2453685

PMID:
18356405

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Diabetes Care

Abbreviation: Diabetes Care

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy.
Tozzo V; Genco M; Omololu SO and 12 more (2024) - Transparency Score: 3/6
Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotra…
Umapathysivam MM; Gunton J; Stranks SN and 1 more (2024) - Transparency Score: 2/6
Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australi…
Hocking SL; Markovic TP; Lee CMY and 3 more (2024) - Transparency Score: 3/6
Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes.
Virostko J; Wright JJ; Williams JM and 18 more (2024) - Transparency Score: 3/6
Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes.
Foster TP; Jacobsen LM; Bruggeman B and 11 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"R.F. has served as a consultant to Pfizer."

Evidence found in paper:

"This research was sponsored by Pfizer."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025